STUDIES ON INFLUENZAL MENINGITIS : I. THE PROBLEMS OF SPECIFIC THERAPY by Ward, Hugh K. & Wright, Joyce
STUDIES  ON  INFLUENZAL MENINGITIS 
1. THE  PROBLEMS  O~ SPECIFIC THERAPY* 
BY HUGH  K. WARD, M.B.,  AND JOYCE WRIGHT, B.M.,  B.Cm 
(From tke Department of Bacteriology and Immunology of tke Harvard University 
Medical Sckool, Boston) 
(Received for publication, November 9, 1931) 
INTRODUCTION 
Whatever the relation of Pfeiffer's Bacillus influenzae to epidemic in- 
fluenza-and that is not under discussion here  there is no doubt that 
this organism is the cause of influenzal meningitis, a  disease that is 
much more common than is generally realized.  The records of The 
Children's Hospital, Boston, disclose that in the last 5 years there have 
been 56 cases of meningococcus meningitis and 25 cases of influenzal 
meningitis in  children under 2  years of age.  In both  diseases the 
cases have occurred only sporadically during this period. 
Influenzal meningitis is a disease of infancy and early childhood and 
is almost always fatal.  Rivers (1), in an analysis from the literature of 
220 cases under 2 years of age, gives k mortality of 92 per cent.  It is 
remarkable that no record can be found of any attempt being made to 
treat these cases with an appropriate antiserum, despite the striking 
results that have been obtained with antimeningococcus serum.  Woll- 
stein  (2) in  1911 injected antiserum intraspinally 24 hours after she 
had infected a  rhesus monkey, the animal recovering, but no account 
can be found of the use of this serum in human cases.  Rivers (3) has 
pointed out, and this has been our own experience, that the strains of 
the influenza bacillus that are found in influenzal meningitis are fairly 
homogeneous, thus simplifying the problem of specific serum  treat- 
ment.  Under these circumstances we thought it worth while to in- 
vestigate the possibility of specific therapy.  Through the courtesy 
of the Massachusetts  Antitoxin Laboratory,  after some months we 
* This work was largely financed by the Philip Ellis Stevens, Jr., Memorial 
Gift. 
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had available for use the serum of a horse that had been injected with 
formalized cultures of B. influenzae  that had been recently isolated 
from cases of the disease.  This antiserum was tried on a  number of 
cases,  some 10  to  12  cc. being injected intraspinally either once or 
twice a day.  Although the serum agglutinated the organisms isolated 
from the cases and was therefore apparently specific, it had no effect 
whatever on the course of the disease, and influenza bacilli could be 
cultured from every specimen of cerebrospinal fluid up to the day of 
death. 
The disappointing clinical results with this antiserum and the in- 
formation that it  contained no precipitins  1 prompted us to make a 
more thorough investigation into the problem instead of merely treat- 
ing the patients empirically with a specifically agglutinating antiserum. 
Howwas this investigation to be carried out?  Direct animal experimen- 
tation was not promising, because none of the ordinary laboratory ani- 
mals are susceptible to virulent B. influenzae except in large doses and 
there is very little margin between the lethal dose of living organisms 
and the lethal dose of dead organisms.  This suggests that the toxicity 
of the culture is of much greater importance than the virulence in over- 
coming the resistance of the animals and in the beginning at any rate 
it was the virulence-resistance mechanism rather than the toxicity of 
the organism that we wished to study. 
In the case of the pneumococcus, bactericidal tests either with whole 
blood or mixtures of leucocytes and serum have given useful informa- 
tion in the problems of pneumonia, several workers, including one of 
the authors, having employed this technique in recent years.  With 
this  experience as a  general guide, it  was  decided to  use a  similar 
method in influenzal meningitis, but one modified to meet the special 
characteristics of the influenza bacillus.  It is admitted that, in at- 
tempting to find out what goes on in the body in infectious diseases by 
studying the behaviour of the specific virus in the blood only, one has 
to be very cautious in drawing inferences.  For although the serum 
and leucocytes may be the most important part of the defense mechan- 
ism,  they are still  only a  part.  Nevertheless, the technique of the 
bactericidal blood test is so easy and simple compared to in vivo tests 
1 We owe this knowledge to Dr. Margaret Pittman of The Rockefeller Institute 
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that  it  facilitates  the  study  of  the  practical  problems  of  specific 
therapy, as well as the study of the relationship between defences of 
the parasite  (upon which virulence depends)  and  the  defences of the 
host  (upon  which  resistance  depends).  And  in  diseases  in  which 
there is no susceptible animal available, it seemed to us the only way 
at present to study these problems. 
Technique 
The technique used in these experiments is essentially one devised originally 
by Todd, but slightly modified  by one of the authors and  described in previous 
publications  (4).  One  determines the  maximum number  of organisms that  a 
constant amount of the whole defibrinated blood will kill, in the following manner: 
Known but varying numbers of organisms are incubated for 24 hours with the 
constant amount of blood (0.5 cc.) in small, sealed test-tubes placed in a rotating 
box.  The tubes are then broken open and the contents plated out  to determine 
growth or sterility.  Growth products of the organisms or antibodies or both can 
be added to the contents of the tubes before incubation if one wishes to study the 
effect of these  substances on  the bactericidal action  of the blood.  Details  of 
technique can be found in  the original communication (4). 
In working with B. influenzae, certain minor changes have been made: 
1.  In experiments involving phagocytosis, human defibrillated whole blood has 
been used, because rabbit blood is not suitable for this purpose, but in all other ex- 
periments rabbit defibrinated whole blood has been employed.  Fresh rabbit serum 
has been tried occasionally, but the results are the same as with the whole blood, 
and it is more convenient to use the blood.  In some experiments where it was 
desirable to reduce the bactericidal power of the normal blood in order to show the 
effect of adding antibody, the blood has been diluted with an equal volume of 5 
per cent pepsin-digested horse blood broth.  There is still enough complement left 
in this special blood broth mixture to show bactericidal action in the presence of 
antibody, and this digested blood broth is an excellent medium for the B. influen- 
zae.  Fildes  (5)  advocated the use of this broth and described the  method  of 
preparation in 1920. 
2.  The smooth, virulent cultures of B. influenzae have been kept in defibrinated 
rabbit blood for the greater part of the time.  As far as we can tell, this method has 
been successful  in maintaining the original virulence of the cultures, a  very im- 
portant consideration in most bacteriological work, and especially in studies of 
this nature.  The organism growing out from the culture of cerebrospinal fluid is 
inoculated into about 0.5 cc. of fresh, defibrinated rabbit blood in either a sealed or 
a wool-plugged  tube.  The tube is incubated for 24 hours and then placed in the 
ice box.  At the end of 10 days a tube of 5 per cent digested blood broth is in- 
oculated from the blood tube.  The broth culture is incubated and the process 
repeated. 226  INFLUENZAL  MENINGITIS.  I 
The rough, non-virulent cultures of B. influenzae have been kept in the 5 per 
cent digested blood broth in the ice box, transplanting at 10 day intervals. 
3.  When a culture of the virulent organism is wanted for the bactericidal blood 
test, an 18 hour culture is made in the 5 per cent digested blood broth from one of 
the stock blood tubes described  above. 
4.  At the end of the incubation of the blood tubes in the bactericidal test, the 
tubes are broken open and their contents plated out with a platinum loop on to 
chocolate agar instead of blood agar. 
EXPERIMENTAL 
In any test involving the bactericidal action of the blood on a  cer- 
tain species of organism, it is obviously necessary to begin by analys- 
ing this action.  Generally speaking, the Gram-positive organisms are 
first sensitized by the antibody in the serum and then phagocyted by 
the leucocytes, no organisms being killed in the absence of the cells; 
but with the  Gram-negative organisms,  the cells play a  very minor 
r61e, the bacteria being sensitized by the antibody and then killed by 
the complement.  Under  certain conditions the  sensitized organisms 
are  not  only killed,  but undergo  lysis.  B.  influenzae  falls into this 
category, but it was found that the cerebrospinal fluid in cases of in- 
fluenzal meningitis never contained a  trace of complement, but leuco- 
cytes were always present, often in great numbers.  Under these cir- 
cumstances it was desirable to find out whether phagocytosis of the 
bacilli could occur in  the presence of antibody and  cells, but in  the 
absence of complement. 
Table I  shows the results of an experiment designed to demonstrate the bac- 
tericidal action of the various constituents of normal human blood against a viru- 
lent culture of B. influenzae.  The blood was separated into serum and cells by 
centrifugation.  Part of the serum was heated to 56°C. for 30 minutes.  The cells 
were washed four times with saline before using.  Antiserum in various concen- 
trations was added to the cells, because the cells with saline or with heated serum 
had no bactericidal action at all. 
Table I  shows: 
1.  That 1.0 cc. of normal human blood can  kill at least 10,000,000 
virulent influenza bacilli,  and  it  may  be  asked  how  does  this  very 
strong bactericidal power of the blood fit in with the known suscepti- 
bility of human beings to influenzal meningitis, if such findings are at 
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adult blood, but not of infant blood, and influenzal meningitis is  a 
disease  of  infancy.  This,  however,  is  a  subject  for  separate  in- 
vestigation. 
2.  That the action of the unheated normal serum alone is just as 
strong as that of the whole blood, and that the cells either with saline 
or heated normal serum have no action at all.  In other words, the 
bactericidal  action  of  normal  whole blood  against  B.  influenzae is 
wholly due to the natural antibody-complement mechanism. 
3.  That the organism does not grow well in heated normal  serum 
alone, but that there can be no bactericidal action, as is shown by the 
TABLE  I 
No, of 
organisms 
added 
5,000,000 
500,000 
50,000 
5,000 
500 
50 
5 
Whole 
blood 
I 
Unheated ' 
serum 
o 
o 
o 
o 
o 
o 
o 
Heated 
serllin 
++ 
++ 
++  %+ 
.+ 
Washed 
cells 
s~ne 
I-++-t 
k++-t 
k++-t 
~-++q 
~-++q 
k++q 
k++q 
Washed 
heated 
seDlm 
k++-~ 
~++-~ 
,++-~ 
-++-~ 
-++-~ 
Washed cells +  heated serum + 
concentration of antiserum 
1/20  1/200 
++++1+++4 
++++1 +++  I ÷++÷ 
o  + 
o  I  o 
1/2,000 
++++ 
++++ 
++++ 
++ 
+ 
0 
0 
Here, and in the following  tables, + + + +, + + +, + +, +  = vario~ degrees 
of growth.  0 sterility. 
addition of cells to the heated serum, the cells probably supplying a 
necessary growth factor. 
4.  That the addition of antiserum to the cells and heated serum re- 
sults in a very slight bactericidal action  presumably by phagocytosis. 
Kolmer (6) pointed out several years ago that complement was ab- 
sent  from the  cerebrospinal fluid of cases of influenzal meningitis, 
and this finding has been confirmed in the present investigation.  It is 
interesting in this connection that Dr. L. D. FothergiU of The Chil- 
dren's Hospital, Boston, has shown the presence of complement in the 
cerebrospinal fluid of all cases of meningococcus meningitis that he has 
tested.  The method of carrying out the test for complement in the 
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The  results  of  the  above  experiment and  the  proved  absence of 
complement in the cerebrospinal fluid in this disease showed that a 
modification of the treatment was essential, since although leucocytes 
are present in the cerebrospinal fluid, nothing but a  very feeble bac- 
tericidal action could be brought about by the injection of antiserum 
alone.  The obvious change that was indicated was the introduction of 
complement along with the antiserum, as indeed had been advocated 
by Kolmer (6).  This method of treatment has now been tried on 8 
cases. 
In the first 5 cases (which are reported in another paper) some improvement 
took place temporarily, although all of the 5 patients died eventually.  In the 
next 2 cases, the disease was very far advanced on admission  to hospital, and not 
even temporary improvement was noted.  The most encouraging feature of the 
first 5 cases was the fact that the cerebrospinal fluid was sterilized at one time or 
another during the disease, in 1 case for 5 days, in a second case for 10 days and in 
a third  case for 14 days.  Clinical  improvement coincided with the temporary 
sterilization of the cerebrospinal fluid.  Autopsy findings in these cases showed 
that abscesses were definitely  walled off from the general subarachnoid  space, and 
presumably the walls of the abscess protected the organisms from the action of the 
antiserum and complement.  The eighth case, reported to us by Dr. A. Kuttner 
of the Johns Hopkins Hospital, was a child aged 2½ years, admitted 3 days after 
the onset of influenzal  meningitis.  The child was treated daily with the influenzal 
antiserum and human complement.  The cerebrospinal fluid was found to be 
sterile 24 hours after the first treatment, it remained  sterileand the child recovered. 
It is clear from these cases that it is possible to sterilize the main 
subarachnoid space, provided the treatment is commenced reasonably 
early in the disease, but it is not clear how the formation of abscesses 
is to be prevented or how they are to be treated once they have formed, 
because their site at the base of the brain taxes the technique of the 
most  highly  skilled  brain  surgeon.  To  prevent  the  formation  of 
abscesses in this region, Dr. F. D. Ingraham and Dr. L. D. Fothergill 
are attempting to find a  better method of introducing the antiserum 
and complement than by simple lumbar or ventricular injection, and 
provided the cases are diagnosed early enough--this is perhaps  the 
greatest of the difficulties one has to contend against--they have not 
lost hope of eventually being able to overcome the obstacle of abscess 
formation. 
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complement as ef~cient as possible, since it is logical to assume that the 
more rapidly the meninges are sterilized, the less likely is the formation 
of abscesses. 
In the case of antimeningococcus serum, in which no animal test is 
available,  it  is  customary to  rely on  agglutination  as  a  test  of the 
efficiency of the antiserum.  Accordingly, when our original supply of 
antiinfluenza  serum  agglutinated  a  certain  meningeal  strain  of  the 
influenza bacillus up to a dilution of 1/1000, we assumed that it would 
be effective as a bactericidal serum.  After some months, however, we 
began  to  have some doubts,  especially when Dr.  Margaret  Pittman 
tested it and found that it contained no precipifins.  It was at this 
time that we began to investigate the whole problem more thoroughly, 
TABLE  17 
No. of  Concentration of Antiserum A  Concentration of Antiserum B  Control, 
organisms  ,  no anti: 
in tube  1/2,500 1/25,000 1/250,000  1/25  1/250 1/2,500 1/25,00( 1/250,000  serum 
200,000 
20,000 
2,000 
200 
20 
1/25  1/~o 
÷;;÷÷÷÷÷÷÷ 
+  +  +  +  0  0  +  + 
o  +  +  +  +  +  o  o  +  + 
o  +  +  +  +  +  o  o  o  + 
o  o  o  o  o  +  o  o  o  o 
+ 
+ 
+ 
+ 
o 
and obviously one of the first things was to  test the bactericidal ac- 
tion of the antiserum. 
In setting up the experiment, the results of which are shown in Table II, we 
compared the bactericidal action of the original antiserum (Antiserum A) agglu- 
tinating B. influenzae in a dilution of 1/1000, with serum taken some months later 
from the same horse (Antiserum B).  The horse was being regularly injected with 
formalized cultures throughout all this period.  Antiserum B  agglutinated the 
same meningeal strain of B. influ~zae up to a dilution of 1/8000. 
Normal rabbit blood diluted with equal parts of 5 per cent digested blood broth 
was used as the source of complement.  (Each tube contains 0.5 cc. of this rabbit 
blood broth mixture, a known amount of antiserum and a known number of or- 
ganisms.  The tubes were sealed,  incubated, then broken open and plated out. 
The details of this technique have already been referred to. 
Table II shows that the original Antiserum A, although it had an agglutination 
titre of 1/1000, had a bactericidal action in a concentration of 1/25 only (compare 
with control); whereas Antiserum B, with an agglutination titre of 1/8000, had a 230  INFLUENZAL  MENINGITIS.  I 
slight bactericidal action in a concentration of 1/25,000.  In other words, a serum 
which was but eight times stronger in its agglutinating action was approximately 
a thousand times stronger in its bactericidal action.  This discrepancy is analysed 
in Paper II. 
We need hardly say that from this time onwards Antiserum B  was 
used in the treatment of the cases.  Actually, it was used for the first 
time on the first of the 8 cases previously mentioned. 
It will be noticed in Table II that the strong Antiserum B shows the 
Neisser-Wechsberg phenomenon very plainly, in that the strong con- 
centration of this antiserum has no bactericidal action at all, in con- 
trast to the marked action of the weak concentrations.  The reasons 
for this phenomenon are still in dispute, but is has been known for a 
long time that for optimal action, complement and antibody have to 
be present in certain definite proportions to one another.  These ex- 
periments are always carried out in vitro, and we do not know for cer- 
tain whether this law holds good in vivo as well, but if and until  there 
is definite evidence to the contrary, we must assume that it is true in 
vivo.  And here  in  the  treatment  of influenzal  meningitis,  when we 
attempt to introduce a  bactericidal mixture of complement and anti- 
body into the subarachnoid space, we come face to face with the prac- 
tical  application  of the law.  In  other  words,  how much  antiserum 
and how much complement are we going to inject, so that the mixture 
shall have the optimal effect?  The answer to this question is not a 
matter of working out a  simple problem in arithmetic,  as may appear 
at first sight.  The  dilution  factor,  the diffusion factor and  the  ab- 
sorption factor in the cerebrospinal fluid are all uncertain.  Further, 
we have  evidence  that  the  antiserum  forms  a  specific precipitation 
with the cerebrospinal fluid, and we would suspect that the antiserum 
would be thereby weakened, not to speak of the probability that com- 
plement  would  be  adsorbed  by this  specific precipitate.  We have 
indeed noted in one case, where 12.0 cc. of fresh, human serum (active 
as complement in a final concentration of 1/150 in vitro)  was injected 
by the lumbar route, not a  trace of complement could be detected in 
the cerebrospinal fluid 2 hours later.  It must be admitted that so far 
we have not had the courage to advise a  change in the proportion  of 
antiserum  to complement,  and  15 cc. of antiserum  and 6 to 8  cc. of 
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disease.  Most  of  the  cases  responded  favourably  at  first,  and  one 
has to be very sure of a theory to change a treatment under these con- 
ditions.  However,  the  above  proportion  is  probably  far  from  the 
optimal, and in the light of the ultimate fate of most of these cases, 
some modification  in  the  proportion  of antiserum  appears  to  be  in- 
dicated. 
In order to gain as much information as possible on this point, we 
have recently carried out some experiments designed to simulate the 
conditions  in  the  cerebrospinal fluid. 
The experiments have shown that the stronger the concentration of complement, 
the better the sterilizing effect, so that in the experiment shown in Table III we 
TABLE  III 
No. of 
organisms 
in ~uoc 
~,000,000 
700,000 
70,000 
7,000 
7OO 
70 
7 
Fresh human serum +  concentration of 
antiserum 
1/15 
++ 
+++ 
++ 
++ 
++ 
+ 
+ 
1/150 
++% 
% 
% 
o 
o 
% 
1/1,500 1/15,0~ 
++++++ 
++++++ 
++  +++ 
+  ++ 
0  ++ 
0  ++ 
0  ++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
Fresh guinea pig serum +  concentration of 
antiserum 
1/15 
+ 
++ 
+ 
++ 
+ 
1/150 
o 
o 
o 
o 
o 
o 
1/1,500 
+++ 
+++ 
+++ 
+ 
+ 
o 
o 
1/15,000 
+++ 
+++ 
+++ 
o 
o 
0 
0 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
have worked with a complement concentration of 1/7.5 in saline.  Saline was used 
as the diluent instead of the special broth, because although the organisms do not 
grow out as well, and the results are more irregular, saline approximates much 
more closely  to cerebrospinal fluid.  A complement concentration of 1/7.5  was 
used,  because that  is approximately the  final  concentration  one might  expect 
on injecting 10.0 cc. of fresh serum into the cerebrospinal fluid of a young child. 
Finally, the effect of fresh guinea pig serum was compared to that of fresh human 
serum, because of the known high complement content of the former serum. 
Each tube in this experiment then contains 0.5 cc. of a  1/7.5  dilution of fresh 
human serum (or fresh guinea pig serum) in saline, together with a known amount 
of antiserum and a known number of organisms.  The tubes were sealed,  incu- 
bated, broken open and plated out as before. 
Despite the minor irregularities, Table III shows the Neisser-Wechs- 
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concentration of complement, a concentration of approximately 1/150 
of this  antiserum gives the optimum sterilizing effect.  On  the  as- 
sumption that the volume of the cerebrospinal fluid of a child is about 
75.0 cc., it would suggest the injection of only 0.5 cc. of the antiserum 
instead of the 10.0 cc. or more that is ordinarily injected.  The experi- 
ment also shows that fresh guinea pig serum is more effective  than fresh 
human serum.  Actually, this specimen of guinea pig serum was four 
times more active than the human serum, when tested on sensitized 
red cells.  This is consistent with our previous statement (based on 
other experiments) that the higher the concentration of complement, 
the greater the sterilizing effect. 
It is fully realised that the inferences to be drawn from this experi- 
ment rest on no very secure foundation, because the experiment itself 
is based on the assumption that the conditions in vitro approximate 
the conditions in vivo,  and we are very far from sure of this.  Never- 
theless,  one  can  hardly ignore  the  test-tube  evidence that  a  large 
amount of fresh guinea pig serum with a  relatively small amount of 
antiserum is the optimal bactericidal mixture to inject in these cases. 
DISCUSSION 
The results  achieved so far  with the specific  serum treatment of in- 
fluenzal  meningitis compare unfavorably with the results  of similar 
treatment in meningococcus meningitis. Too little  is  known of both 
diseases  to permit of any definite  reason being given for this. At the 
same time, the disease  processes  differ  in at least  two ways: 
I. Complement is present in meningococcus meningitis, absent in 
influenzal  meningitis. 
2. Abscesses appear to be walled off  quite early  in influenzal  men- 
ingitis. 
Although the cerebrospinal  fluid  was sterilized  temporarily in most 
of  these cases,  the  sterilization  took some days to  effect,  and it  is  prob- 
ably significant  that  in  the  one  case  in  which the sterilization  was per- 
manent, the cerebrospinal  fluid  was found free  of organisms 24 hours 
after  the first  treatment, just  as  in  successfully  treated  meningococcus 
meningitis. 
The antiserum in the presence of complement has a strong bacteri- 
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jected complement from the cerebrospinal fluid leaves some doubt as 
to the efficiency of this method of supplying the missing complement. 
Unfortunately, in the one case in which the fluid was sterilized immedi- 
ately and the patient recovered, we have no information as to the pres- 
ence or absence of complement in the fluid before treatment with anti- 
serum and complement was commenced. 
Early diagnosis in this disease is no doubt a very important factor 
indeed, and was perhaps the main reason why one case was treated 
successfully.  But the cases are often in an advanced stage when ad- 
mitted to hospital and the fact that even these cases sometimes show 
a temporary improvement under treatment gives a little hope that if 
the  surgical  and  serological  techniques  can  be  improved,  some  of 
them may be  cured.  "Diagnosed too  late"  perhaps  comes to  the 
tongue too readily, if treatment is unsuccessful. 
CONCLUSIONS 
1.  An acute purulent meningitis due to the invasion of the meninges 
by Pfeiffer's influenza bacillus is not a  very uncommon disease in- 
infants and young children.  It has a very high mortality. 
2.  Complement is entirely absent in the cerebrospinal fluid of these 
cases,  and bactericidal experiments suggest  that  the injection of a 
specific antiserum will have but slight lethal effect on the organisms 
unless complement is injected at the same time. 
3.  Treatment with a mixture of specific antiserum and complement 
led in some cases to a  definite clinical improvement, coincident with 
sterilization and clearing of the cerebrospinal fluid.  But after some 
days, the patients relapsed and died.  Autopsy showed localized ab- 
scesses in the vicinity of the base of the brain, the lesions being defin- 
itely walled off from the general subarachnoid space.  In one case, the 
patient recovered. 
4.  Since the walls of the abscesses apparently present an insuperable 
mechanical obstacle to the action of the antiserum and complement, 
the possibility of preventing the formation of abscesses is discussed. 
Earlier  diagnosis  and more rapid sterilization are the most obvious 
measures.  Bactericidal experiments indicate that  the proportion of 
antiserum  to  complement may be  an important  factor in  bringing 
about a more rapid elimination of the bacilli. 234  INFLUENZAL MENINGITIS.  I 
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